Current Use of Intravenous (IV) Long Acting Antibiotic (LAA) Therapy in the Aetna Health Plan among Patients with Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Por Mehta, Rajesh, Edwards, Alison, Keyloun, Katelyn R, Bonine, Nicole, Juster, Iver
Publicado no Open Forum Infect Dis (2017)

The SWEET SPOTS study: a real-world interpretation of the 2012 American Diabetes Association Position Statement regarding individualized A1C targets

Por Bieszk, Nella, Grabner, Michael, Wei, Wenhui, Bonine, Nicole G, Stephenson, Judith J
Publicado no Risk Manag Healthc Policy (2016)

Associations Between Timeliness of Therapy and Clinical and Economic Outcomes Among Patients With Serious Infections Due to Gram-negative Bacteria (GNB): How Much Does Delayed Appr...

Por Bonine, Nicole G, Berger, Ariel, Altincatal, Arman, Wang, Rosa, Bhagnani, Tarun, Gillard, Patrick, Lodise, Thomas
Publicado no Open Forum Infect Dis (2017)

Carbapenem-resistant Enterobacteriaceae (CRE) or Delayed Appropriate Therapy (DAT)—Does One Affect Outcomes More Than the Other Among Patients With Serious Infections Due to Entero...

Por Lodise, Thomas, Berger, Ariel, Altincatal, Arman, Wang, Rosa, Bhagnani, Tarun, Gillard, Patrick, Bonine, Nicole G
Publicado no Open Forum Infect Dis (2017)

Clinical characteristics, patterns of lipid-lowering medication use, and health care resource utilization and costs among patients with atherosclerotic cardiovascular disease

Por Power, Thomas P, Ke, Xuehua, Zhao, Zhenxiang, Bonine, Nicole Gidaya, Cziraky, Mark J, Grabner, Michael, Barron, John J, Quimbo, Ralph, Vangerow, Burkhard, Toth, Peter P
Publicado no Vasc Health Risk Manag (2018)